“Non-Cystic Fibrosis Bronchiectasis Market” report has been added to DelveInsight
The Non-Cystic Fibrosis Bronchiectasis Market report provides an edge while developing business strategies, by understanding trends shaping and driving the global Non-Cystic Fibrosis Bronchiectasis Market
Download free sample copy here- https://www.delveinsight.com/sample-request/non-cystic-fibrosis-bronchiectasis-ncfb-market
Non-Cystic Fibrosis Bronchiectasis Disease Overview
Non‐cystic fibrosis bronchiectasis (NCFB) is a chronic, progressive respiratory disorder characterized by irreversibly and abnormally dilated airways, persistent cough, excessive sputum production, and recurrent pulmonary infections. Non‐cystic fibrosis bronchiectasis often coexists with other respiratory conditions, such as chronic obstructive pulmonary disease.
Non-Cystic Fibrosis Bronchiectasis Geography Covered
Non-Cystic Fibrosis Bronchiectasis Key Players
Non-Cystic Fibrosis Bronchiectasis Drugs
Non-Cystic Fibrosis Bronchiectasis Prevalence
Prevalence of NCFB is reported to be higher in females. The prevalence of NCFB vary among populations, but studies report an overall prevalence ranging from 486 to 1106 per 100,000 persons with an incidence that appears to be rising, particularly in women and older individuals.
Non-Cystic Fibrosis Bronchiectasis Market Report
NCFB results in irreversible changes in the bronchial walls which may occur due to chronic inflammation secondary to recurrent or chronic infections in the lung, but often the exact cause is not identified. Symptoms vary from intermittent episodes of respiratory infections with excessive mucus production to chronic symptoms with persistent daily expectoration of purulent sputum.
Non-Cystic Fibrosis Bronchiectasis Market Outlook
When a specific disorder is found to cause bronchiectasis, disease management is then primarily directed at the underlying cause. While in case of Non‐Cystic Fibrosis Bronchiectasis management is aimed at preventing disease progression and improving quality of life by reducing symptoms and exacerbations.
Treatment is based on breaking the vicious cycle using mucoactive treatments and airway clearance techniques (ACTs) to enhance mucus clearance, inhaled or oral antibiotic therapy to reduce chronic bronchial infection, anti-inflammatory therapies to decrease associated inflammation, bronchodilator therapy, surgery, and pulmonary rehabilitation. Many treatment options for non-CF bronchiectasis are derived from the treatment regimens developed for cystic fibrosis.
Non-Cystic Fibrosis Bronchiectasis Physiotherapy
Most patients with bronchiectasis, especially those with excessive secretions, are offered physiotherapy. Forced expiratory manoeuvres, as well as hand-held devices generating positive expiratory pressure (‘pep’ devices), such as Flutter or Acapella, are used for optimal sputum clearance.
Non-Cystic Fibrosis Bronchiectasis Market Report Scope
Following is the TOC Market Report
1. Key Insights
2. Executive Summary of Non-Cystic Fibrosis Bronchiectasis (NCFB)
3. Competitive Intelligence Analysis for Non-Cystic Fibrosis Bronchiectasis (NCFB)
4. Non-Cystic Fibrosis Bronchiectasis (NCFB): Market Overview at a Glance
5. Non-Cystic Fibrosis Bronchiectasis (NCFB): Disease Background and Overview
6. Patient Journey
7. Non-Cystic Fibrosis Bronchiectasis (NCFB) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Non-Cystic Fibrosis Bronchiectasis (NCFB) Treatment
11. Marketed Products
12. Emerging Therapies
13. Non-Cystic Fibrosis Bronchiectasis (NCFB): Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Non-Cystic Fibrosis Bronchiectasis (NCFB)
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Why should you buy this report?
Related Reports
Non-Cystic Fibrosis Bronchiectasis Epidemiology
DelveInsight’s Non-Cystic Fibrosis Bronchiectasis Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology
Non-Cystic Fibrosis Bronchiectasis Pipeline
Non-Cystic Fibrosis Bronchiectasis (NCFB) Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Vinita Rakheja Email: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: www.delveinsight.com/